Delivery Order SPE2DB22D1002-SPE2DB24FKTC5
Award Date
10/19/23
Potential Completion Date
10/20/23
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,328.78, is for the delivery of COPAXONE 40 MG/ML syringes, a specialty medication. The contract has an ultimate completion date of June 17, 2024 and is a Firm Fixed Price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Copaxone 20 mg/mL syringes to support the Defense Logistics Agency (DLA) Troop Support Medical. The $1,083.79 firm fixed-price delivery order has a completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,055.54 delivery order is for the supply of COPAXONE 40 MG/ML syringes and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,414.56 firm fixed-price delivery order is for the supply of COPAXONE 20 MG/ML syringes, a medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,583.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of November 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,964.56 firm fixed-price delivery order is for the supply of COPAXONE 40 MG/ML syringes, with a completion date of June 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award, with the ID SPE2DB22D1002|SPE2DB25FKXZ1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,652.47 firm fixed-price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication, with a completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of COPAXONE 40 MG/ML SYRINGE ML pharmaceutical products. The firm fixed price delivery order has a potential value of $3,562.48 and a completion date of February 13, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceutical and medical...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of COPAXONE 40 MG/ML syringes. The $2,297.04 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is not associated with a set-aside program and has an ultimate completion date of September 4, 2024. Amerisourcebergen is one of...
This federal contract award is for the delivery of Copaxone 40 mg/ml syringes, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,638.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...